Publications by authors named "Voduc David"

Claim this Profile
S
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
Timothy J Whelan, Sally Smith, Sameer Parpia, Anthony W Fyles, Anita Bane, K David Voduc

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity.
Nafisha Lalani, K David Voduc, Rachel B Jimenez, Nathalie Levasseur, Lovedeep Gondara

Int J Radiat Oncol Biol Phys· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, David E Larson, David Voduc

Nat Commun· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic effects of somatic mutations in ER-positive breast cancer.
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, David E Larson, David Voduc

Nat Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
Karama Asleh, Jennifer R Won, Dongxia Gao, K David Voduc, Torsten O Nielsen

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
Tinne Laurberg, Trine Tramm, Torsten Nielsen, Jan Alsner, Silje Nord, David Voduc

Acta Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
αB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis.
K David Voduc, Torsten O Nielsen, Charles M Perou, J Chuck Harrell, Cheng Fan

NPJ Breast Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.
Fei-Fei Liu, Wei Shi, Susan J Done, Naomi Miller, Melania Pintilie, David Voduc, David R McCready

J Clin Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, Aleix Prat, David Voduc

Oncologist· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
Wilson Sheridan, Tyldesley Scott, Speers Caroline, Zheng Yvonne, Bernstein Vanessa, Voduc David

Breast Cancer Res Treat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
Maggie C U Cheang, K David Voduc, Dongsheng Tu, Shan Jiang, Samuel Leung

Clin Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Torsten O Nielsen, Joel S Parker, Samuel Leung, David Voduc, Mark Ebbert

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic behavior of breast cancer subtypes.
Hagen Kennecke, Rinat Yerushalmi, Ryan Woods, Maggie Chon U Cheang, David Voduc

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.
Connie G Chiu, Hamid Masoudi, Samuel Leung, David K Voduc, Blake Gilks, David G Huntsman

Ann Surg· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer subtypes and the risk of local and regional relapse.
K David Voduc, Maggie C U Cheang, Scott Tyldesley, Karen Gelmon, Torsten O Nielsen

J Clin Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, David Voduc, Dongxia Gao, Samuel Leung

J Natl Cancer Inst· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
David Voduc, Torsten O Nielsen

Clin Breast Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
David Voduc, Torsten O Nielsen, Maggie C Cheang, William D Foulkes

Hum Pathol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microarrays in clinical oncology.
David Voduc, Challayne Kenney, Torsten O Nielsen

Semin Radiat Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney

Clin Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
David Voduc, Maggie Cheang, Torsten Nielsen

Cancer Epidemiol Biomarkers Prev· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Ashish B Rajput, Dmitry A Turbin, Maggie Cu Cheang, David K Voduc, Sam Leung, David G Huntsman

Breast Cancer Res Treat· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
Scott Tyldesley, David Voduc, Michael McKenzie, Graeme Duncan, Mitchell Liu

Urology· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis